• Publications
  • Influence
Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study.
BACKGROUND/AIMS Treatment of hepatorenal syndrome (HRS) is based on vasoconstrictors. Terlipressin is the one with the soundest evidence. Noradrenalin has been suggested as an effective alternative.Expand
  • 234
  • 20
Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis.
BACKGROUND/AIMS Treatment with hepatitis B virus immune globulins (HBIG) or lamivudine has reduced the rate of hepatitis B recurrence after liver transplantation to approximately 50%. METHODS ToExpand
  • 215
  • 11
Clinical outcome of HBeAg‐negative chronic hepatitis B in relation to virological response to lamivudine
The effect of lamivudine treatment on the outcome of patients with hepatitis B e antigen (HBeAg)‐negative chronic hepatitis is unclear. In a retrospective multicenter study, we have analyzed theExpand
  • 267
  • 10
Prophylaxis and treatment of hepatitis B in immunocompromised patients
The literature on hepatitis B virus (HBV) in immunocompromised patients is heterogeneous and referred mainly to the pre-antivirals era. Today a rational approach to the problem of hepatitis B inExpand
  • 145
  • 8
Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2
Objectives Renal failure secondary to hepatorenal syndrome or to organic renal disease occurs frequently in cirrhotic patients with portal hypertension. The present prospective study investigates theExpand
  • 140
  • 8
Prophylaxis and treatment of hepatitis B in immunocompromised patients.
The literature on hepatitis B virus (HBV) in immunocompromised patients is heterogeneous and referred mainly to the pre-antivirals era. Today a rational approach to the problem of hepatitis B inExpand
  • 86
  • 5
Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
BACKGROUND & AIMS Transient elastography (TE) is validated in chronic hepatitis C (CHC) to evaluate hepatic fibrosis; however, limited data are available in chronic hepatitis B (CHB) andExpand
  • 173
  • 4
COBAS AmpliPrep-COBAS TaqMan Hepatitis B Virus (HBV) Test: a Novel Automated Real-Time PCR Assay for Quantification of HBV DNA in Plasma
ABSTRACT Success in antiviral therapy for chronic hepatitis B is supported by highly sensitive PCR-based assays for hepatitis B virus (HBV) DNA. Nucleic acid extraction from biologic specimens isExpand
  • 53
  • 4
Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.
BACKGROUND Paracentesis-induced circulatory dysfunction is a well-known complication of large volume paracentesis. Albumin infusion (8g of albumin/L of ascites removed) is effective in preventing it,Expand
  • 52
  • 3
Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence
Hepatitis B virus (HBV) recurrence after liver transplantation is significantly reduced by prophylaxis with hepatitis B immune globulins (HBIG) or antiviral drugs in nonreplicating patients and byExpand
  • 157
  • 2